Tarsus Pharmaceuticals (TARS) Tax Rate (2020 - 2026)

Tarsus Pharmaceuticals' (TARS) quarterly Tax Rate came in at 53.0% in Q1 2026, down 238382.69% quarter-over-quarter from 0.02% in Q3 2022.

Tarsus Pharmaceuticals (TARS) Tax Rate (2020 - 2026) Analysis & Trends

Tarsus Pharmaceuticals' Tax Rate history runs 4 years deep, the most recent figure standing at 53.0% for Q1 2026.

On a quarterly basis, Tax Rate changed N/A year-over-year to 53.0% in Q1 2026; TTM through Mar 2026 was 1.63%, a N/A change from a year earlier, with the FY2025 full-year figure at 3.2%, changed N/A from the prior year.
Tax Rate eased to 53.0% in Q1 2026 per TARS's latest filing, from 0.02% in the prior quarter.
Across five years, Tax Rate topped out at 0.02% in Q3 2022 and bottomed at 53.0% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-0.34%
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	12.29%
4	NuCana	279.75 Bn	279.75 Bn	-	-5.41%
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	17.68%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	12.51%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	33.09%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Tarsus Pharmaceuticals	2.52 Bn	2.41 Bn	152.66 Mn	-53.00%

Download Data